HopeStage
Back to all studies
RecruitingNCT03923374

Maternal and infant health after opioid use in pregnancy

About this title

Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes

Read the official source — NCT03923374
Observational studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
PittsburghSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 15, 2018
Recruitment status
Recruiting
Enrollment listed in the registry
600
Sponsor
Senthil Sadhasivam
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
DIAGNOSTIC_TEST, Medication / drug
Study phase
Not clearly listed
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT03923374
Official title
Show the full official title

Effects of Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes

Recruitment & locations

Currently recruiting

Pittsburgh

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Senthil Sadhasivam.

Does this study involve medication?

Yes. The study involves medication, including Subutex / Buprenorphine.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies